Liraglutide

Venkatasai is a leading provider of pharmaceutical reference standards, specializing in the supply of high-purity Liraglutide reference materials. Our portfolio includes both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamine derivatives (N-NO products). These reference standards play a crucial role in pharmaceutical R&D, aiding in formulation development, ANDA/DMF submissions, quality control, method validation, stability studies, and impurity profiling—including the identification and assessment of potentially genotoxic impurities.

Each Liraglutide-related product is rigorously characterized and delivered with a detailed Certificate of Analysis (COA) and comprehensive analytical data to ensure regulatory compliance. Upon request, we also offer EP/USP traceable standards. To maintain the highest quality standards, all materials are subject to periodic re-testing and continuous quality monitoring.

Liraglutide

Picture of Liraglutide
CAT No: VS-L097000
CAS No: 204656-20-2
Mol.F.: C172H265N43O51
Mol.Wt.: 3751.3
Status: Custom Synthesis

D-Ser(8)-Liraglutide

Picture of D-Ser(8)-Liraglutide
CAT No: VS-L097001
CAS No: NA
Mol.F.: C172H265N43O51
Mol.Wt.: 3751.26
Status: Custom Synthesis

D-Glu-(17)-Liraglutide

Picture of D-Glu-(17)-Liraglutide
CAT No: VS-L097002
CAS No: NA
Mol.F.: C172H264N42O52
Mol.Wt.: 3752.25
Status: Custom Synthesis

D-allo-Thr(11)-Liraglutide

Picture of D-allo-Thr(11)-Liraglutide
CAT No: VS-L097003
CAS No: NA
Mol.F.: C172H265N43O51
Mol.Wt.: 3751.56
Status: Custom Synthesis

Contact

040-23076623, 040-4852 9278

E-Mail

info@venkatasailifesciences.com